BIOCRYST PHARMACEUTICALS$3.24
-0.02
| Last Trade: |
3.24 |
| Trade Time: |
May 25 11:41 AM Eastern Daylight Time |
| Change: |
-0.02 (-0.61 %) |
| Prev Close: |
3.26 |
| Open: |
3.27 |
| Bid: |
3.23 |
| Ask: |
3.24 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/15/2012
|
STAAB THOMAS R II
|
Senior Vice President and CFO
|
-4,162
|
$5.23
|
-10.08%
|
|
3/15/2012
|
Stonehouse Jon P
|
President & CEO
|
-13,612
|
$5.23
|
-4.84%
|
|
3/15/2012
|
LOWREY ROBERT S
|
Controller, PAO
|
-2,686
|
$5.23
|
-21.57%
|
|
3/15/2012
|
McCullough David
|
VP
|
-5,307
|
$5.23
|
-18.03%
|
|
3/15/2012
|
Sheridan William P
|
SR VP - CMO
|
-7,543
|
$5.23
|
-14.45%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (BCRX), click here.
-
Investors follow momentum trends because positive sentiment on a company can cause the momentum to persist.
Read More »
-
If you're looking for cutting-edge companies that have a chance to triple or quadruple in the coming months and years, don't look any further than today's best small biotechs, writes Mike Murphy of ...
Read More »
Free Reports
|
|
